
Benzinga Pro data, Caribou Biosciences (NASDAQ:CRBU) reported Q1 sales of $2.66 million. Earnings fell to a loss of $19.09 million, resulting in a 3.3% decrease from last quarter. Caribou Biosciences collected $2.56 million in revenue during Q4, but reported earnings showed a $18.48 million loss.